Anika Therapeutics ANIK Net Income
Net Income at other companies
Other financials
Where this comes from
Reported directly by Anika Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:NetIncomeLoss.
The official record: Anika Therapeutics’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Anika Therapeutics's net income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Anika Therapeutics's net income?
- Anika Therapeutics (ANIK) reported net income of -$5.06M in Q1 2026.
- How has Anika Therapeutics's net income changed year-over-year?
- Anika Therapeutics's net income decreased by 3.8% year-over-year, from -$4.87M to -$5.06M.
- What is the long-term trend for Anika Therapeutics's net income?
- Over 3 years (2022 to 2025), Anika Therapeutics's net income has grown at a -9.1% compound annual growth rate (CAGR), from -$14.86M to -$11.17M.
- What does net income mean?
- The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.